About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 338   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Safety of Receiving Anti–Vascular Endothelial Growth Factor Intravitreal Injection in Office-Based vs Operating Room Settings
Tong Li,Junran Sun,Jingyu Min,Shuangwen Zhou,Xiaolin Zhu,Huixun Jia,Xiaodong Sun
JAMA Ophthalmology.2021;139(10)1080
[DOI]
2Outcomes of three intravitreal injections of bevacizumab given monthly for diabetic macular oedema is a viable treatment for an economically disadvantaged population
Aazambir S. Brar,Vivek B. Wani,Arvind L. Tenagi
African Vision and Eye Health.2021;80(1)1080
[DOI]
3Staphylococcus lugdunensis Endophthalmitis: Case Series and Literature Review
Kuan-Jen Chen,Ming-Hui Sun,Andrew S. H. Tsai,Chi-Chin Sun,Wei-Chi Wu,Chi-Chun Lai
Antibiotics.2022;11(11)1485
[DOI]
4POOLED ESTIMATES OF INCIDENCE OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS WITH AND WITHOUT TOPICAL ANTIBIOTIC PROPHYLAXIS
Michele Reibaldi,Alfredo Pulvirenti,Teresio Avitabile,Vincenza Bonfiglio,Andrea Russo,Cesare Mariotti,Claudio Bucolo,Rodolfo Mastropasqua,Guglielmo Parisi,Antonio Longo
Retina.2018;38(1)01
[DOI]
5Incidence and Risk Factors for Post-Intravitreal Injection Endophthalmitis in a Modified Operating Room Setting
Mohammad Zarei,Reza Karkhaneh,Razieh Mahmoudzadeh,Mirataollah Salabati,Amin Nabavi,Mehdi Yaseri,Ehsan Najibzadeh,Ramak Roohipoor,Mohammad Riazi Esfahani,Alireza Khodabande,Fariba Ghassemi,Nazanin Ebrahimiadib,Hasan Khojasteh,Bobeck S. Modjtahedi
Ocular Immunology and Inflammation.2019;27(8)1314
[DOI]
6Bevacizumab
Mohammad Zarei,Reza Karkhaneh,Razieh Mahmoudzadeh,Mirataollah Salabati,Amin Nabavi,Mehdi Yaseri,Ehsan Najibzadeh,Ramak Roohipoor,Mohammad Riazi Esfahani,Alireza Khodabande,Fariba Ghassemi,Nazanin Ebrahimiadib,Hasan Khojasteh,Bobeck S. Modjtahedi
Reactions Weekly.2016;1592(1)47
[DOI]
7Endophthalmitis Following Intravitreal Injections Performed in the Office Versus Operating Room Setting
Joshua H. Uhr,Jason Hsu
Current Ophthalmology Reports.2019;7(2)128
[DOI]
8Incidence of Acute Endophthalmitis After Intravitreal Bevacizumab Injection at a Tertiary Care Hospital in Lahore
Nasir Ahmed,Hafeez Ur Rehman,Memoona Rafique,Muhammad S Hamza,Huma A Mirza
Cureus.2021;7(2)128
[DOI]
9Incidence of endophthalmitis after intravitreal injections at a tertiary care hospital
Sidra Zafar,Arsalan Hamid,Syed Usman Bin Mahmood,Maqsood Ahmad Burq,Natasha Maqsood
Canadian Journal of Ophthalmology.2018;53(2)94
[DOI]
10Fungal Eye Infections: New Hosts, Novel Emerging Pathogens but No New Treatments?
Christina C. Chang,Sharon C-A Chen
Current Fungal Infection Reports.2018;12(2)66
[DOI]
112018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations
Andrzej Grzybowski,Reinhard Told,Stefan Sacu,Francesco Bandello,Elad Moisseiev,Anat Loewenstein,Ursula Schmidt-Erfurth
Ophthalmologica.2018;239(4)181
[DOI]
  Feedback 
  Subscribe 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal